BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teruel AH, Pérez-Esteve É, González-Álvarez I, González-Álvarez M, Costero AM, Ferri D, Parra M, Gaviña P, Merino V, Martínez-Mañez R, Sancenón F. Smart gated magnetic silica mesoporous particles for targeted colon drug delivery: New approaches for inflammatory bowel diseases treatment. J Control Release 2018;281:58-69. [PMID: 29753956 DOI: 10.1016/j.jconrel.2018.05.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Singh P, Waghambare P, Khan T, Omri A. Colorectal cancer management: Strategies in drug delivery. Expert Opin Drug Deliv 2022. [PMID: 35656670 DOI: 10.1080/17425247.2022.2084531] [Reference Citation Analysis]
2 Kulkarni N, Jain P, Shindikar A, Suryawanshi P, Thorat N. Advances in the colon-targeted chitosan based drug delivery systems for the treatment of inflammatory bowel disease. Carbohydrate Polymers 2022. [DOI: 10.1016/j.carbpol.2022.119351] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
3 Badinezhad M, Soleimani M, Jafari S. Stimuli responsive nano-composite co-delivery of Doxorubicin and ciprofloxacin using HPLC-UV combined spectroscopy methods. Materials Today Communications 2022;30:103128. [DOI: 10.1016/j.mtcomm.2022.103128] [Reference Citation Analysis]
4 Zhou S, Zhong Q, Wang Y, Hu P, Zhong W, Huang C, Yu Z, Ding C, Liu H, Fu J. Chemically engineered mesoporous silica nanoparticles-based intelligent delivery systems for theranostic applications in multiple cancerous/non-cancerous diseases. Coordination Chemistry Reviews 2022;452:214309. [DOI: 10.1016/j.ccr.2021.214309] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 27.0] [Reference Citation Analysis]
5 Kotla NG, Singh R, Baby BV, Rasala S, Rasool J, Hynes SO, Martin D, Egan LJ, Vemula PK, Jala VR, Rochev Y, Pandit A. Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease. Biomaterials 2022;281:121364. [DOI: 10.1016/j.biomaterials.2022.121364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Garcia-carrasco M, Parra-aguilar IF, Gutiérrez-grijalva EP, Licea-claverie A, Basilio Heredia J. Nano-formulations in drug delivery. Food, Medical, and Environmental Applications of Nanomaterials 2022. [DOI: 10.1016/b978-0-12-822858-6.00017-0] [Reference Citation Analysis]
7 Parodi A, Buzaeva P, Nigovora D, Baldin A, Kostyushev D, Chulanov V, Savvateeva LV, Zamyatnin AA Jr. Nanomedicine for increasing the oral bioavailability of cancer treatments. J Nanobiotechnology 2021;19:354. [PMID: 34717658 DOI: 10.1186/s12951-021-01100-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
8 Zhuo Z, Wang J, Luo Y, Zeng R, Zhang C, Zhou W, Guo K, Wu H, Sha W, Chen H. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles. Acta Biomater 2021;134:13-31. [PMID: 34284151 DOI: 10.1016/j.actbio.2021.07.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
9 García-Fernández A, Sancho M, Bisbal V, Amorós P, Marcos MD, Orzáez M, Sancenón F, Martínez-Máñez R. Targeted-lung delivery of dexamethasone using gated mesoporous silica nanoparticles. A new therapeutic approach for acute lung injury treatment. J Control Release 2021;337:14-26. [PMID: 34265332 DOI: 10.1016/j.jconrel.2021.07.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
10 Poyatos-Racionero E, González-Álvarez I, Sánchez-Moreno P, Sitia L, Gatto F, Pompa PP, Aznar E, González-Álvarez M, Martínez-Máñez R, Marcos MD, Bernardos A. Lactose-Gated Mesoporous Silica Particles for Intestinal Controlled Delivery of Essential Oil Components: An In Vitro and In Vivo Study. Pharmaceutics 2021;13:982. [PMID: 34209675 DOI: 10.3390/pharmaceutics13070982] [Reference Citation Analysis]
11 Pahwa R, Bajaj R, Bhateja P, Piplani M. Recent Advances in Colon Drug Delivery Technology. DDL 2021;11:110-135. [DOI: 10.2174/2210303111666210129143612] [Reference Citation Analysis]
12 Bhaskaran NA, Kumar L. Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems. J Control Release 2021;336:16-39. [PMID: 34118336 DOI: 10.1016/j.jconrel.2021.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
13 Cheng S, Shen H, Zhao S, Zhang Y, Xu H, Wang L, Di B, Xu L, Hu C. Orally administered mesoporous silica capped with the cucurbit[8]uril complex to combat colitis and improve intestinal homeostasis by targeting the gut microbiota. Nanoscale 2020;12:15348-63. [PMID: 32648873 DOI: 10.1039/d0nr03037f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
14 Zeleňáková A, Szűcsová J, Nagy Ľ, Girman V, Zeleňák V, Huntošová V. Magnetic Characterization and Moderate Cytotoxicity of Magnetic Mesoporous Silica Nanocomposite for Drug Delivery of Naproxen. Nanomaterials (Basel) 2021;11:901. [PMID: 33915918 DOI: 10.3390/nano11040901] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Caspi M, Wittenstein A, Kazelnik M, Shor-Nareznoy Y, Rosin-Arbesfeld R. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv Drug Deliv Rev 2021;169:118-36. [PMID: 33346022 DOI: 10.1016/j.addr.2020.12.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 36.0] [Reference Citation Analysis]
16 González-Alvarez I, Vivancos V, Coll C, Sánchez-Dengra B, Aznar E, Ruiz-Picazo A, Bermejo M, Sancenón F, Dea-Ayuela MA, Gonzalez-Alvarez M, Martínez-Máñez R. pH-Dependent Molecular Gate Mesoporous Microparticles for Biological Control of Giardia intestinalis. Pharmaceutics 2021;13:94. [PMID: 33451061 DOI: 10.3390/pharmaceutics13010094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Singh VK, Singh V, Tyagi V. Recent Update on Nanomedicine-Based Drug Targeting on Colon Cancer. Colon Cancer Diagnosis and Therapy 2021. [DOI: 10.1007/978-3-030-64668-4_14] [Reference Citation Analysis]
18 Deshmukh R, Harwansh RK, Rahman MA. Sodium alginate-guar gum and carbopol based methotrexate loaded mucoadhesive microparticles for colon delivery: An in vitro evaluation. Braz J Pharm Sci 2021;57:e19147. [DOI: 10.1590/s2175-97902020000419147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Teruel AH, Gonzalez-Alvarez I, Bermejo M, Merino V, Marcos MD, Sancenon F, Gonzalez-Alvarez M, Martinez-Mañez R. New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy. Int J Mol Sci 2020;21:E6502. [PMID: 32899548 DOI: 10.3390/ijms21186502] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
20 Baradaran Eftekhari R, Maghsoudnia N, Samimi S, Abedin Dorkoosh F. Application of Chitosan in Oral Drug Delivery. In: Jana S, Jana S, editors. Functional Chitosan. Singapore: Springer; 2019. pp. 43-73. [DOI: 10.1007/978-981-15-0263-7_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Chaubey P, Momin M, Sawarkar S. Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders. Front Pharmacol 2019;10:1628. [PMID: 32161536 DOI: 10.3389/fphar.2019.01628] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Lee SH, Bajracharya R, Min JY, Han JW, Park BJ, Han HK. Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements. Pharmaceutics 2020;12:E68. [PMID: 31952340 DOI: 10.3390/pharmaceutics12010068] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 35.5] [Reference Citation Analysis]
23 García-Fernández A, Aznar E, Martínez-Máñez R, Sancenón F. New Advances in In Vivo Applications of Gated Mesoporous Silica as Drug Delivery Nanocarriers. Small 2020;16:e1902242. [PMID: 31846230 DOI: 10.1002/smll.201902242] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 21.0] [Reference Citation Analysis]
24 Tung N, Nguyen C, Nguyen V, Nguyen T, Nguyen V, Tran C, Pham T. Formulation and in vivo imaging evaluation of colonic targeting tablets prepared by a simple dry powder coating technique. J Pharm Investig 2020;50:383-98. [DOI: 10.1007/s40005-019-00463-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Hernández montoto A, Llopis‐lorente A, Gorbe M, M. terrés J, Cao‐milán R, Díaz de greñu B, Alfonso M, Ibañez J, Marcos MD, Orzáez M, Villalonga R, Martínez‐máñez R, Sancenón F. Janus Gold Nanostars–Mesoporous Silica Nanoparticles for NIR‐Light‐Triggered Drug Delivery. Chem Eur J 2019;25:8471-8. [DOI: 10.1002/chem.201900750] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
26 Bernardos A, Piacenza E, Sancenón F, Hamidi M, Maleki A, Turner RJ, Martínez-Máñez R. Mesoporous Silica-Based Materials with Bactericidal Properties. Small 2019;15:e1900669. [PMID: 31033214 DOI: 10.1002/smll.201900669] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 26.0] [Reference Citation Analysis]
27 Teruel AH, Pérez-esteve É, González-álvarez I, González-álvarez M, Costero AM, Ferri D, Gaviña P, Merino V, Martínez-máñez R, Sancenón F. Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease. Mol Pharmaceutics 2019;16:2418-29. [DOI: 10.1021/acs.molpharmaceut.9b00041] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
28 Suzuki H. Remarkable diversification of bacterial azoreductases: primary sequences, structures, substrates, physiological roles, and biotechnological applications. Appl Microbiol Biotechnol 2019;103:3965-78. [PMID: 30941462 DOI: 10.1007/s00253-019-09775-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
29 Ferri D, Costero AM, Gaviña P, Parra M, Merino V, Teruel AH, Sancenón F, Martínez-Máñez R. Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis. Int J Pharm 2019;561:93-101. [PMID: 30817986 DOI: 10.1016/j.ijpharm.2019.02.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
30 Vass P, Démuth B, Hirsch E, Nagy B, Andersen SK, Vigh T, Verreck G, Csontos I, Nagy ZK, Marosi G. Drying technology strategies for colon-targeted oral delivery of biopharmaceuticals. J Control Release 2019;296:162-78. [PMID: 30677436 DOI: 10.1016/j.jconrel.2019.01.023] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 17.7] [Reference Citation Analysis]